Study eligibility criteria for Systemic corticosteroids plus standard care vs. standard care (plus/minus placebo) - Clinical Practice Guidelines (CPG) on EBMonFHIR v1.2.0

Clinical Practice Guidelines (CPG) on EBMonFHIR
1.2.0 - qa-preview

This page is part of the CPG-on-EBMonFHIR Implementation Guide (1.2.0).

Example EvidenceVariable: Study eligibility criteria for Systemic corticosteroids plus standard care vs. standard care (plus/minus placebo)

Active as of 2025-03-04

Generated Narrative: EvidenceVariable StudyEligibilityCriteriaSystemicCorticosteroidsCOVID19

Profile: Study Eligibility Criteria

url: EvidenceVariable StudyEligibilityCriteriaSystemicCorticosteroidsCOVID19

name: StudyEligibilityCriteriaSystemicCorticosteroidsCOVID19

status: Active

date: 2025-03-04 10:04:34+0000

characteristic
DefinitionByTypeAndValues
- Type Value[x]
* Clinical finding (finding) Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)